Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG. Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG Post navigation Previous: Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech SummitNext: Regulus Therapeutics Reports First Quarter 2025 Financial Results and Recent Updates
